Caribou Biosciences, Inc.
Caribou Biosciences, Inc. (CRBU) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRBU · as of Jun 8, 2026
Key Statistics
Explore Caribou Biosciences, Inc. Data
crbu stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 100.0%
The CRBU analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +166.67% upside from the current price of $1.88.
Competitors & Peers
crbu competitorsCRBU
AARD
ALLO
ENTA
FHTX
HUMAStock Performance
Full HistoryAbout Caribou Biosciences, Inc.
Caribou Biosciences, Inc. a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tum…
what is caribou biosciences, inc. · crbu stock overview · caribou biosciences, inc. company profile · who is caribou biosciences, inc. ceo · crbu NASDAQ · caribou biosciences, inc. headquarters · caribou biosciences, inc. business segments
About Stock Overview & Key Data
Caribou Biosciences, Inc. (CRBU) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 23, 2021. As of the latest trading session, CRBU stock price is $1.88, with a market capitalization of $186.5M. The stock has returned +48.03% over the past 12 months and +18.24% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Caribou Biosciences, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Caribou Biosciences, Inc. reported revenue of $11.2M and net income of -$148.1M. For detailed data — including Caribou Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Caribou Biosciences, Inc. (CRBU) stock price is $1.88. The stock is traded on NASDAQ under the ticker symbol CRBU. The 52-week range is $1.04 – $3.54.